(ING) ING - Overview
Exchange: NYSE •
Country: Netherlands •
Currency: USD •
Type: Common Stock •
ISIN: US4568371037
Stock:
Total Rating 55
Risk 84
Buy Signal 0.62
| Risk 5d forecast | |
|---|---|
| Volatility | 24.8% |
| Relative Tail Risk | -4.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.08 |
| Alpha | 65.03 |
| Character TTM | |
|---|---|
| Beta | 0.836 |
| Beta Downside | 0.947 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.77% |
| CAGR/Max DD | 1.75 |
EPS (Earnings per Share)
Revenue
Description: ING ING
ING Groep N.V. provides various banking products and services in the Netherlands, Belgium, Germany, rest of Europe, and internationally. The company operates through five segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, and Wholesale Banking. It accepts current and savings accounts, as well as time deposits. The company also offers business lending products; SME loans; consumer lending products, such as residential mortgage loans and other consumer lending loans; and mortgages. In addition, it provides working capital solutions; debt and equity market solutions; various loans; payments; and cash management, trade and corporate finance, and treasury services, as well as savings, investment, insurance, and digital banking services. The company serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 6.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 3.22 > 1.0 |
| NWC/Revenue: -1716 % < 20% (prev -1427 %; Δ -288.2% < -1%) |
| CFO/TA 0.01 > 3% & CFO 10.49b > Net Income 6.33b |
| Net Debt (116.44b) to EBITDA (9.15b): 12.73 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.92b) vs 12m ago -6.84% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 4.00% > 50% (prev 4.40%; Δ -0.40% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
Altman Z''
| A: -0.68 (Total Current Assets 106.31b - Total Current Liabilities 819.08b) / Total Assets 1054.40b |
| B: error (Retained Earnings missing) |
| C: 0.01 (EBIT TTM 9.15b / Avg Total Assets 1037.47b) |
| D: 0.05 (Book Value of Equity 49.70b / Total Liabilities 1003.45b) |
Beneish M
| DSRI: none (Receivables none/984.0m, Revenue 41.55b/44.90b) |
| GMI: 1.01 (GM 96.86% / 97.88%) |
| AQI: 1.01 (AQ_t 0.90 / AQ_t-1 0.88) |
| SGI: 0.93 (Revenue 41.55b / 44.90b) |
| TATA: -0.00 (NI 6.33b - CFO 10.49b) / TA 1054.40b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ING shares?
As of February 27, 2026, the stock is trading at USD 29.52 with a total of 2,280,516 shares traded.
Over the past week, the price has changed by +1.69%, over one month by +1.65%, over three months by +14.76% and over the past year by +78.67%.
Over the past week, the price has changed by +1.69%, over one month by +1.65%, over three months by +14.76% and over the past year by +78.67%.
Is ING a buy, sell or hold?
ING has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold ING.
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ING price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29 | -1.9% |
| Analysts Target Price | 29 | -1.9% |
ING Fundamental Data Overview February 21, 2026
Market Cap EUR = 72.10b (84.98b USD * 0.8484 USD.EUR)
P/E Trailing = 11.5198
P/E Forward = 9.9108
P/S = 3.9107
P/B = 1.3879
P/EG = 1.5739
Revenue TTM = 41.55b EUR
EBIT TTM = 9.15b EUR
EBITDA TTM = 9.15b EUR
Long Term Debt = 169.33b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 169.33b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 116.44b EUR (from netDebt column, last quarter)
Enterprise Value = 135.12b EUR (72.10b + Debt 169.33b - CCE 106.31b)
Interest Coverage Ratio = unknown (Ebit TTM 9.15b / Interest Expense TTM 0.0)
EV/FCF = 13.03x (Enterprise Value 135.12b / FCF TTM 10.37b)
FCF Yield = 7.67% (FCF TTM 10.37b / Enterprise Value 135.12b)
FCF Margin = 24.95% (FCF TTM 10.37b / Revenue TTM 41.55b)
Net Margin = 15.23% (Net Income TTM 6.33b / Revenue TTM 41.55b)
Gross Margin = unknown ((Revenue TTM 41.55b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Tobins Q-Ratio = 0.13 (Enterprise Value 135.12b / Total Assets 1054.40b)
Interest Expense / Debt = 0.03% (Interest Expense 45.0m / Debt 169.33b)
Taxrate = 28.93% (606.0m / 2.10b)
NOPAT = 6.50b (EBIT 9.15b * (1 - 28.93%))
Current Ratio = 0.13 (Total Current Assets 106.31b / Total Current Liabilities 819.08b)
Debt / Equity = 3.41 (Debt 169.33b / totalStockholderEquity, last quarter 49.70b)
Debt / EBITDA = 12.73 (Net Debt 116.44b / EBITDA 9.15b)
Debt / FCF = 11.23 (Net Debt 116.44b / FCF TTM 10.37b)
Total Stockholder Equity = 49.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.61% (Net Income 6.33b / Total Assets 1054.40b)
RoE = 12.66% (Net Income TTM 6.33b / Total Stockholder Equity 49.98b)
RoCE = 4.17% (EBIT 9.15b / Capital Employed (Equity 49.98b + L.T.Debt 169.33b))
RoIC = 2.97% (NOPAT 6.50b / Invested Capital 218.91b)
WACC = 2.70% (E(72.10b)/V(241.43b) * Re(8.99%) + D(169.33b)/V(241.43b) * Rd(0.03%) * (1-Tc(0.29)))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.61%
[DCF] Terminal Value 80.82% ; FCFF base≈10.37b ; Y1≈6.81b ; Y5≈3.11b
[DCF] Fair Price = N/A (negative equity: EV 98.94b - Net Debt 116.44b = -17.51b; debt exceeds intrinsic value)
EPS Correlation: 54.92 | EPS CAGR: 51.51% | SUE: 2.41 | # QB: 2
Revenue Correlation: 13.25 | Revenue CAGR: 6.37% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.67 | Chg7d=+0.668 | Chg30d=+0.668 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.77 | Chg7d=+0.010 | Chg30d=+0.159 | Revisions Net=+2 | Growth EPS=+9.6% | Growth Revenue=+4.3%
EPS next Year (2027-12-31): EPS=3.04 | Chg7d=+0.106 | Chg30d=+0.127 | Revisions Net=+1 | Growth EPS=+9.8% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 0.3% (Discount Rate 9.0% - Earnings Yield 8.7%)
[Growth] Growth Spread = +1.3% (Analyst 1.6% - Implied 0.3%)
P/E Trailing = 11.5198
P/E Forward = 9.9108
P/S = 3.9107
P/B = 1.3879
P/EG = 1.5739
Revenue TTM = 41.55b EUR
EBIT TTM = 9.15b EUR
EBITDA TTM = 9.15b EUR
Long Term Debt = 169.33b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 169.33b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 116.44b EUR (from netDebt column, last quarter)
Enterprise Value = 135.12b EUR (72.10b + Debt 169.33b - CCE 106.31b)
Interest Coverage Ratio = unknown (Ebit TTM 9.15b / Interest Expense TTM 0.0)
EV/FCF = 13.03x (Enterprise Value 135.12b / FCF TTM 10.37b)
FCF Yield = 7.67% (FCF TTM 10.37b / Enterprise Value 135.12b)
FCF Margin = 24.95% (FCF TTM 10.37b / Revenue TTM 41.55b)
Net Margin = 15.23% (Net Income TTM 6.33b / Revenue TTM 41.55b)
Gross Margin = unknown ((Revenue TTM 41.55b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Tobins Q-Ratio = 0.13 (Enterprise Value 135.12b / Total Assets 1054.40b)
Interest Expense / Debt = 0.03% (Interest Expense 45.0m / Debt 169.33b)
Taxrate = 28.93% (606.0m / 2.10b)
NOPAT = 6.50b (EBIT 9.15b * (1 - 28.93%))
Current Ratio = 0.13 (Total Current Assets 106.31b / Total Current Liabilities 819.08b)
Debt / Equity = 3.41 (Debt 169.33b / totalStockholderEquity, last quarter 49.70b)
Debt / EBITDA = 12.73 (Net Debt 116.44b / EBITDA 9.15b)
Debt / FCF = 11.23 (Net Debt 116.44b / FCF TTM 10.37b)
Total Stockholder Equity = 49.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.61% (Net Income 6.33b / Total Assets 1054.40b)
RoE = 12.66% (Net Income TTM 6.33b / Total Stockholder Equity 49.98b)
RoCE = 4.17% (EBIT 9.15b / Capital Employed (Equity 49.98b + L.T.Debt 169.33b))
RoIC = 2.97% (NOPAT 6.50b / Invested Capital 218.91b)
WACC = 2.70% (E(72.10b)/V(241.43b) * Re(8.99%) + D(169.33b)/V(241.43b) * Rd(0.03%) * (1-Tc(0.29)))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.61%
[DCF] Terminal Value 80.82% ; FCFF base≈10.37b ; Y1≈6.81b ; Y5≈3.11b
[DCF] Fair Price = N/A (negative equity: EV 98.94b - Net Debt 116.44b = -17.51b; debt exceeds intrinsic value)
EPS Correlation: 54.92 | EPS CAGR: 51.51% | SUE: 2.41 | # QB: 2
Revenue Correlation: 13.25 | Revenue CAGR: 6.37% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.67 | Chg7d=+0.668 | Chg30d=+0.668 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.77 | Chg7d=+0.010 | Chg30d=+0.159 | Revisions Net=+2 | Growth EPS=+9.6% | Growth Revenue=+4.3%
EPS next Year (2027-12-31): EPS=3.04 | Chg7d=+0.106 | Chg30d=+0.127 | Revisions Net=+1 | Growth EPS=+9.8% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 0.3% (Discount Rate 9.0% - Earnings Yield 8.7%)
[Growth] Growth Spread = +1.3% (Analyst 1.6% - Implied 0.3%)